Bambino Gesù Hospital And Research Institute
Clinical trials sponsored by Bambino Gesù Hospital And Research Institute, explained in plain language.
-
New immune cell therapy offers hope for kids with Tough-to-Treat leukemia
Disease control Recruiting nowThis study is testing a new cell therapy called CD7-CART01 in children and young adults (6 months to 25 years old) whose T-cell leukemia or lymphoma has come back or hasn't responded to standard treatments. Doctors will first find the safest dose and then see if the treatment can…
Phase: PHASE1, PHASE2 • Sponsor: Bambino Gesù Hospital and Research Institute • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New hope for kids with tough leukemia: donor cell therapy trial opens
Disease control Recruiting nowThis early-stage trial is testing a new type of cell therapy for children and young adults whose B-cell leukemia has come back or hasn't responded to other treatments. Doctors are using immune cells from a donor, engineered to target the cancer, to see if this approach is safe an…
Phase: PHASE1 • Sponsor: Bambino Gesù Hospital and Research Institute • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC